Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Proceedings of the National Academy of Sciences of the United States of America
|
March 25, 2022
Structural determinants of dual incretin receptor agonism by tirzepatide
Bingfa Sun, Francis S Willard, Dan Feng, et al.
Journal of Medicinal Chemistry
|
April 2, 2005
Design of potent and selective 2-aminobenzimidazole-based p38alpha MAP kinase inhibitors with excellent in vivo efficacy
Alfonso de Dios, Chuan Shih, Beatriz López de Uralde, et al.
Molecular Cancer Therapeutics
|
January 30, 2004
The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridines
Chafiq Hamdouchi, Heather Keyser, Elizabeth Collins, et al.
ACS Infectious Diseases
|
February 22, 2022
Identification of β-Lactams Active against <i>Mycobacterium tuberculosis</i> by a Consortium of Pharmaceutical Companies and Academic Institutions
Ben Gold, Jun Zhang, Landys Lopez Quezada, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Proceedings of the National Academy of Sciences of the United States of America
|
March 25, 2022
Structural determinants of dual incretin receptor agonism by tirzepatide
Bingfa Sun, Francis S Willard, Dan Feng, et al.
Journal of Medicinal Chemistry
|
April 2, 2005
Design of potent and selective 2-aminobenzimidazole-based p38alpha MAP kinase inhibitors with excellent in vivo efficacy
Alfonso de Dios, Chuan Shih, Beatriz López de Uralde, et al.
Molecular Cancer Therapeutics
|
January 30, 2004
The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridines
Chafiq Hamdouchi, Heather Keyser, Elizabeth Collins, et al.
ACS Infectious Diseases
|
February 22, 2022
Identification of β-Lactams Active against <i>Mycobacterium tuberculosis</i> by a Consortium of Pharmaceutical Companies and Academic Institutions
Ben Gold, Jun Zhang, Landys Lopez Quezada, et al.
Page
of 4